Yatin Suneja
Stock Analyst at Guggenheim
(2.45)
# 2,361
Out of 4,876 analysts
136
Total ratings
44.54%
Success rate
-0.1%
Average return
Main Sectors:
Stocks Rated by Yatin Suneja
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LRMR Larimar Therapeutics | Reiterates: Buy | $26 | $3.01 | +763.79% | 6 | Jun 25, 2025 | |
| ALMS Alumis | Reinstates: Buy | $18 | $3.12 | +476.92% | 2 | Jun 10, 2025 | |
| ANAB AnaptysBio | Maintains: Buy | $54 → $90 | $23.07 | +290.12% | 13 | May 28, 2025 | |
| CABA Cabaletta Bio | Maintains: Buy | $23 → $25 | $1.70 | +1,370.59% | 5 | May 16, 2025 | |
| ARGX argenx SE | Maintains: Buy | $1,100 → $1,065 | $560.52 | +90.00% | 10 | May 9, 2025 | |
| GHRS GH Research | Maintains: Buy | $32 → $29 | $12.35 | +134.91% | 1 | May 9, 2025 | |
| NBIX Neurocrine Biosciences | Maintains: Buy | $155 → $165 | $126.54 | +30.39% | 5 | May 6, 2025 | |
| PHAT Phathom Pharmaceuticals | Maintains: Buy | $18 → $12 | $9.88 | +21.46% | 4 | May 2, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $940 → $810 | $527.00 | +53.70% | 6 | May 1, 2025 | |
| ZURA Zura Bio | Reiterates: Buy | $15 | $1.13 | +1,227.43% | 2 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $10 | $0.81 | +1,134.42% | 5 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $0.67 | +942.29% | 1 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $16.09 | - | 8 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $84 | $17.86 | +370.32% | 1 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $9.94 | +352.72% | 3 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.78 | - | 2 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $7.95 | - | 3 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $45 | $8.95 | +402.79% | 3 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 | $22.23 | -10.03% | 6 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.59 | - | 2 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $16.46 | - | 2 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $65 | $15.70 | +314.01% | 1 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $155 → $170 | $42.93 | +295.99% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $9.39 | - | 3 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $7.42 | +573.85% | 1 | Apr 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $90 | $21.01 | +328.37% | 5 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $125 | $105.10 | +18.93% | 8 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $16 | $11.48 | +39.37% | 2 | Nov 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $77 | $47.54 | +61.97% | 3 | Nov 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.92 | - | 3 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $49 | $32.24 | +51.99% | 2 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $55 | $9.95 | +452.76% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $270 → $350 | $127.45 | +174.62% | 3 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $9.27 | - | 5 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.65 | - | 3 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $12.43 | +93.16% | 1 | May 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $34 | $93.84 | -63.77% | 2 | Jan 14, 2020 |
Larimar Therapeutics
Jun 25, 2025
Reiterates: Buy
Price Target: $26
Current: $3.01
Upside: +763.79%
Alumis
Jun 10, 2025
Reinstates: Buy
Price Target: $18
Current: $3.12
Upside: +476.92%
AnaptysBio
May 28, 2025
Maintains: Buy
Price Target: $54 → $90
Current: $23.07
Upside: +290.12%
Cabaletta Bio
May 16, 2025
Maintains: Buy
Price Target: $23 → $25
Current: $1.70
Upside: +1,370.59%
argenx SE
May 9, 2025
Maintains: Buy
Price Target: $1,100 → $1,065
Current: $560.52
Upside: +90.00%
GH Research
May 9, 2025
Maintains: Buy
Price Target: $32 → $29
Current: $12.35
Upside: +134.91%
Neurocrine Biosciences
May 6, 2025
Maintains: Buy
Price Target: $155 → $165
Current: $126.54
Upside: +30.39%
Phathom Pharmaceuticals
May 2, 2025
Maintains: Buy
Price Target: $18 → $12
Current: $9.88
Upside: +21.46%
Regeneron Pharmaceuticals
May 1, 2025
Maintains: Buy
Price Target: $940 → $810
Current: $527.00
Upside: +53.70%
Zura Bio
Mar 26, 2025
Reiterates: Buy
Price Target: $15
Current: $1.13
Upside: +1,227.43%
Mar 26, 2025
Maintains: Buy
Price Target: $7 → $10
Current: $0.81
Upside: +1,134.42%
Mar 21, 2025
Reiterates: Buy
Price Target: $7
Current: $0.67
Upside: +942.29%
Mar 20, 2025
Reiterates: Buy
Price Target: n/a
Current: $16.09
Upside: -
Mar 12, 2025
Reiterates: Buy
Price Target: $84
Current: $17.86
Upside: +370.32%
Mar 12, 2025
Reiterates: Buy
Price Target: $45
Current: $9.94
Upside: +352.72%
Mar 10, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.78
Upside: -
Jan 24, 2025
Reiterates: Buy
Price Target: n/a
Current: $7.95
Upside: -
Jan 3, 2025
Upgrades: Buy
Price Target: $45
Current: $8.95
Upside: +402.79%
Jan 3, 2025
Downgrades: Neutral
Price Target: $20
Current: $22.23
Upside: -10.03%
Dec 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.59
Upside: -
Dec 11, 2024
Reiterates: Buy
Price Target: n/a
Current: $16.46
Upside: -
Oct 25, 2024
Maintains: Buy
Price Target: $50 → $65
Current: $15.70
Upside: +314.01%
Aug 14, 2024
Maintains: Buy
Price Target: $155 → $170
Current: $42.93
Upside: +295.99%
May 10, 2024
Downgrades: Neutral
Price Target: n/a
Current: $9.39
Upside: -
Apr 29, 2024
Initiates: Buy
Price Target: $50
Current: $7.42
Upside: +573.85%
Feb 27, 2024
Maintains: Buy
Price Target: $72 → $90
Current: $21.01
Upside: +328.37%
Feb 21, 2024
Maintains: Buy
Price Target: $110 → $125
Current: $105.10
Upside: +18.93%
Nov 15, 2023
Maintains: Buy
Price Target: $17 → $16
Current: $11.48
Upside: +39.37%
Nov 15, 2023
Maintains: Buy
Price Target: $70 → $77
Current: $47.54
Upside: +61.97%
Jul 17, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.92
Upside: -
Jun 15, 2023
Reiterates: Buy
Price Target: $49
Current: $32.24
Upside: +51.99%
May 18, 2023
Maintains: Buy
Price Target: $52 → $55
Current: $9.95
Upside: +452.76%
May 1, 2023
Upgrades: Buy
Price Target: $270 → $350
Current: $127.45
Upside: +174.62%
Jan 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $9.27
Upside: -
Oct 14, 2022
Downgrades: Neutral
Price Target: n/a
Current: $0.65
Upside: -
May 31, 2022
Initiates: Buy
Price Target: $24
Current: $12.43
Upside: +93.16%
Jan 14, 2020
Maintains: Buy
Price Target: $29 → $34
Current: $93.84
Upside: -63.77%